About FDNA

Erik A. Feingold is the CEO and Co-Founder of FDNA Inc. He previously served as President & Head of Strategy at Sharecare (NASDAQ: SHCR) and as a senior advisor to the CEO/Executive Chairman. He joined Sharecare following the acquisition of his company, FeingoldTech GmbH.

Feingold is a distinguished business leader with over 30 years of experience at the intersection of healthcare, technology, and product innovation. His extensive background includes founding and leading high-growth tech and AI businesses, managing M&As and integrating acquisitions, and playing a key role in SHCR $4 billion IPO.

Mr. Shniberg is an innovator, inventor and serial entrepreneur. He has founded several global technology ventures, including Face.com (acquired by Facebook), CyberMDX (acquired by Forescout) and MutualArt, a leading global art information platform with more than 1 Million subscribers. Mr. Shniberg is the inventor behind many patents, which are at the core of globally used solutions, such as Apple’s smart album and Facebook and Instagram’s image tagging. He is currently the founder and driving force behind Nacre Capital, a global venture builder specialized in creating and scaling start-ups that use deep AI technologies to address fundamental global needs and create significant value for society. Nacre Capital’s portfolio includes FDNA, a world-renowned company helping clinicians identify rare diseases in children, Seed-X developing trait detection and sorting technology for grains and seeds, and Fairtility, delivering solutions to significantly increase the efficiency of IVF & reduce time to live birth.

Karen W. Gripp, MD is the Chief Medical Officer for FDNA. She is board certified in Pediatrics and Medical Genetics. Dr. Gripp is a Professor of Pediatrics at the Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA and sees pediatric patients at Nemours Children’s Hospital in Wilmington, DE. Her research focusses on the identification of novel syndromic conditions and their underlying cause, in the context of precision diagnostics for rare, genetic and developmental diseases. She has published more than 200 professional reports.

Aviram has 10+ years of software R&D experience, most of which in a fast-growing corporation environment. For the last 3 years he was the company’s CTO, and managed the AI and ML activities of FDNA. He holds a Computer Engineering BSc from the Hebrew university of Jerusalem, and a MSc in Computer Engineering from Tel Aviv university.

Francisco is General Counsel at FDNA, where he manages all aspects of the company’s legal operations, advises on deal structures, governance and compliance matters. Prior to joining FDNA in 2021, Francisco worked for more than seventeen years in top tier law firms in Argentina, gaining broad experience in Venture Capital, Corporate Law, M&A, Commercial Contracts, Compliance, Litigation and Dispute Resolution. Francisco received his J.D. from the University of Buenos Aires (Argentina) and an LLM from Queen Mary University of London (UK).

Pierluigi is Director of AI at FDNA, where he leads AI and Machine Learning efforts. He has 15+ years of expertise in field of Data and AI working in large enterprises and successful startups where he managed machine learning and data science teams. He holds a PhD in Information Engineering and MSc in Computer Engineering from University of Siena.

Stefanie is the Head of Business Operations at FDNA Inc. She previously served as SVP Product & Technology Operations at Sharecare leading Enterprise implementation, as well as delivering the technologies to support Operation Warp Speed through 2020-2021. She joined Sharecare following the acquisition of FeingoldTech GmbH where she served as Chief Commercial Officer.

Stefanie is an accomplished senior operations executive and corporate strategist, with a proven track record for successful delivery to Fortune 500 clients and consumer markets. She brings 25 years of experience in efficiently rolling out proprietary technologies and leading business operations from self-funded startups to international enterprises.

Moshe Gabay is the Chief Product and Technology officer at FDNA. With over 30 years in field of product and technology, Moshe previously served as EVP Consumer Technology for Sharecare (NSADQ: SHCR), as CTO of Feingold Technologies (acquired by Sharecare), as an independent auditor for enterprise and start-up technology companies and entrepreneur